![Jonathan R. McGrath](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jonathan R. McGrath
Director Ejecutivo en Neograft Technologies, Inc. .
Perfil
Mr. Jonathan R.
McGrath is a President, Director & Treasurer at Neograft Technologies, Inc.
Mr. McGrath was previously employed as a Vice President-Research & Development by BioSphere Medical, Inc., a Vice President-Research & Development by Urologix, Inc., a Vice President-Research & Development by Pfizer Inc., and a Chief Executive Officer by LumeRx, Inc.
He received his undergraduate degree from the University of Vermont.
Cargos activos de Jonathan R. McGrath
Empresas | Cargo | Inicio |
---|---|---|
Neograft Technologies, Inc.
![]() Neograft Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Neograft Technologies, Inc. engages in the research and development in tissue engineering and regenerative medicine. Its product Angioshield, addresses inherent limits associated with using veins for coronary bypass surgery. The company was founded by Mohammed El-Kurdi in 2009 and is headquartered in Taunton, MA. | Director Ejecutivo | - |
Antiguos cargos conocidos de Jonathan R. McGrath.
Empresas | Cargo | Fin |
---|---|---|
BioSphere Medical, Inc.
![]() BioSphere Medical, Inc. Medical SpecialtiesHealth Technology BioSphere Medical, Inc. develops, manufactures and markets microsphere technology to medical applications. The company uses microsphere technology to develop its products for medical applications using embolotherapy techniques. It offers Embosphere Microspheres for uterine fibroids, hypervascularized tumors and other arteriovenous malformations, EmboGold Microspheres for Hypervascularized tumors and arteriovenous malformations, EmboCath Infusion Catheter and Segway Guidewire for peripheral embolization procedures and HepaSphere Microspheres for liver cancer. The company was founded in 1993 and is headquartered in Rockland, MA. | Director Técnico/Científico/I+D | 01/01/2005 |
UROLOGIX, INC. | Director Técnico/Científico/I+D | 01/01/1998 |
PFIZER, INC. | Director Técnico/Científico/I+D | 01/01/1995 |
LumeRx, Inc.
![]() LumeRx, Inc. Medical SpecialtiesHealth Technology LumeRx, Inc. develops radiation technology that eliminates bacteria. It provides minimally invasive and light-based devices for the treatment of peptic ulcer disease. The company was founded by Robert A. Ganz and is headquartered in Newton, MA. | Presidente | - |
Formación de Jonathan R. McGrath.
University of Vermont | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
UROLOGIX, INC. | Health Technology |
PFIZER, INC. | Health Technology |
Empresas privadas | 3 |
---|---|
LumeRx, Inc.
![]() LumeRx, Inc. Medical SpecialtiesHealth Technology LumeRx, Inc. develops radiation technology that eliminates bacteria. It provides minimally invasive and light-based devices for the treatment of peptic ulcer disease. The company was founded by Robert A. Ganz and is headquartered in Newton, MA. | Health Technology |
BioSphere Medical, Inc.
![]() BioSphere Medical, Inc. Medical SpecialtiesHealth Technology BioSphere Medical, Inc. develops, manufactures and markets microsphere technology to medical applications. The company uses microsphere technology to develop its products for medical applications using embolotherapy techniques. It offers Embosphere Microspheres for uterine fibroids, hypervascularized tumors and other arteriovenous malformations, EmboGold Microspheres for Hypervascularized tumors and arteriovenous malformations, EmboCath Infusion Catheter and Segway Guidewire for peripheral embolization procedures and HepaSphere Microspheres for liver cancer. The company was founded in 1993 and is headquartered in Rockland, MA. | Health Technology |
Neograft Technologies, Inc.
![]() Neograft Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Neograft Technologies, Inc. engages in the research and development in tissue engineering and regenerative medicine. Its product Angioshield, addresses inherent limits associated with using veins for coronary bypass surgery. The company was founded by Mohammed El-Kurdi in 2009 and is headquartered in Taunton, MA. | Commercial Services |
- Bolsa de valores
- Insiders
- Jonathan R. McGrath